Last reviewed · How we verify
Sulfabenzid (SULFABENZAMIDE)
At a glance
| Generic name | SULFABENZAMIDE |
|---|---|
| Sponsor | Johnson & Johnson |
| Drug class | sulfabenzamide |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease |
| Phase | FDA-approved |
| First approval | 1945 |
Approved indications
- Gardnerella Vaginalis Bacterial Vaginosis
- Vulvovaginitis
Common side effects
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sulfabenzid CI brief — competitive landscape report
- Sulfabenzid updates RSS · CI watch RSS
- Johnson & Johnson portfolio CI